Antimicrobial Susceptibility Testing, Critical Issues For The 90s, Vol. 349 Book

	Introduction	1
	The Evolution of Antimicrobial Susceptibility Testing Methods	3
	Antimicrobial Susceptibility Tests: Testing Methods and Interpretive Problems	15
	Clinician Utilization of Rapid Antibiotic Susceptibility Data: A Prospective Study	27
	When We Should Be Testing, How Often and What to Report	35
	Areas of Recent Emphasis of the National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility Testing	61
	Non-Traditional Approaches for Quality Control of Antimicrobial Susceptibility Tests	67
	Applications of Medical Informatics in Antibiotic Therapy	87
	Established Antimicrobial Susceptibility Testing Methods with a New Twist - Points to Consider and a Glimpse of the Future	97
	Measures of Susceptibility from a Spiral Gradient of Drug Concentrations	107
	Commercialization of Nucleic Acid Probe Technology: Current Status	121
	Is One Laboratory In Town Enough?	131
	The FDA Review Criteria for Assessment of Antimicrobial Susceptibility Devices - Too Much or Not Enough Regulation?	135
	The Evolution of Clinical Laboratory Regulation - A Primer for Universal Health Care	145
	Current Issues in Antimicrobial Susceptibility Testing	153
	The Use of In-Vitro Kinetic Models in the Evaluation of [beta]-Lactam/[beta]-Lactamase Combinations	157
	Prevalence of Ticarcillin/Clavulanic Acid-Resistant Enterobacteriacaeae in Nine Separate Medical Centers During the Years 1983, 1989, 1991	163
	Correlation of Minimum Inhibitory Concentration Results Between the Vitek System and the Biomic System	177
	Contributors	187
	Index	189